Search research articles
Contact Us
Filters
Showing results (191-200 of 322) with videos related to
Page
of 33
Sort By:
Neurology
|
September 6, 2019
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
Frederik Barkhof, Ludwig Kappos, Jerry S Wolinsky, et al.
Journal of Medical Internet Research
|
October 10, 2019
Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study
Luciana Midaglia, Patricia Mulero, Xavier Montalban, et al.
Journal of Medical Internet Research
|
September 1, 2019
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study
Luciana Midaglia, Patricia Mulero, Xavier Montalban, et al.
Human Molecular Genetics
|
June 11, 2013
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Dorothee Nickles, Hsuan P Chen, Michael M Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2013
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
Hanne F Harbo, Noriko Isobe, Pål Berg-Hansen, et al.
Journal of Autoimmunity
|
April 24, 2019
Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation
Alessandro Didonna, Ester Cantó, Hengameh Shams, et al.
Science Translational Medicine
|
August 8, 2014
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
Arumugam Palanichamy, Leonard Apeltsin, Tracy C Kuo, et al.
Frontiers in Immunology
|
July 2, 2021
High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility
Kazutoyo Osoegawa, Lisa E Creary, Gonzalo Montero-Martín, et al.
The Lancet. Neurology
|
November 1, 2020
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
Jerry S Wolinsky, Douglas L Arnold, Bruno Brochet, et al.
Annals of Neurology
|
August 29, 2012
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M Mowry, Emmanuelle Waubant, Charles E McCulloch, et al.
Page
of 33
Search research articles
Search
Showing results (191-200 of 322) with videos related to
Sort By:
Page
of 33
Neurology
|
September 6, 2019
Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis
Frederik Barkhof, Ludwig Kappos, Jerry S Wolinsky, et al.
Journal of Medical Internet Research
|
October 10, 2019
Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study
Luciana Midaglia, Patricia Mulero, Xavier Montalban, et al.
Journal of Medical Internet Research
|
September 1, 2019
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study
Luciana Midaglia, Patricia Mulero, Xavier Montalban, et al.
Human Molecular Genetics
|
June 11, 2013
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls
Dorothee Nickles, Hsuan P Chen, Michael M Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2013
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
Hanne F Harbo, Noriko Isobe, Pål Berg-Hansen, et al.
Journal of Autoimmunity
|
April 24, 2019
Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation
Alessandro Didonna, Ester Cantó, Hengameh Shams, et al.
Science Translational Medicine
|
August 8, 2014
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
Arumugam Palanichamy, Leonard Apeltsin, Tracy C Kuo, et al.
Frontiers in Immunology
|
July 2, 2021
High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility
Kazutoyo Osoegawa, Lisa E Creary, Gonzalo Montero-Martín, et al.
The Lancet. Neurology
|
November 1, 2020
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial
Jerry S Wolinsky, Douglas L Arnold, Bruno Brochet, et al.
Annals of Neurology
|
August 29, 2012
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
Ellen M Mowry, Emmanuelle Waubant, Charles E McCulloch, et al.
Page
of 33